Current antibacterial therapy of patients with acute rhinosinusitis and exacerbation of chronic rhinosinusitis taking place at the background of bronchial asthma and/or chronic bronchitis
The results of comparative clinical study which include 60 patients with acute maxillary sinusitis (48.4%) and chronic sinusitis exacerbation (51.5%) proceeding against the background of asthma or chronic bronchitis receiving a "nonparacentetic" therapy with levofloxacin 500 mg/daily, or the traditional "paracentetic" treatment with drainage catheter installation, are presented. It is shown that the use of appropriately selected integrated combined scheme of "nonparacentetic" therapy led to recovery or stable remission in 70% of patients, whereas therapeutic effect in the second group was much less pronounced. At the same time, "paracentetic" treatment was accompanied by the development of complications in many patients. The analysis of selected microflora in patients with maxillary sinusitis is presented.

Keywords: paracentetic method, pathogenic microflora, rhinosinusitis, sinusitis, levofloxacin